Next Article in Journal
A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study
Next Article in Special Issue
Prevalence and Risk Factors of Postpartum Depression in Romanian Women during Two Periods of COVID-19 Pandemic
Previous Article in Journal
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis
Previous Article in Special Issue
Planned Place of Birth—Impact of Psychopathological Risk Factors on the Choice of Birthplace and Its Postpartum Effect on Psychological Adaption: An Exploratory Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 11
Issue 2
10.3390/jcm11020349
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Elevated Perinatal Depression during the COVID-19 Pandemic: A National Study among Jewish and Arab Women in Israel

by
Samira Alfayumi-Zeadna
1,*,
Rena Bina
2,
Drorit Levy
2,
Rachel Merzbach
2 and
Atif Zeadna
3
1
MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada
2
The Louis and Gabi Weisfeld School of Social Work, Bar Ilan University, Ramat Gan 5290002, Israel
3
Fertility and IVF Unit, Department of Obstetrics and Gynecology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410402, Israel
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(2), 349; https://doi.org/10.3390/jcm11020349
Submission received: 11 December 2021 / Revised: 7 January 2022 / Accepted: 10 January 2022 / Published: 11 January 2022
(This article belongs to the Special Issue Women’s Health and Perinatal Mood and Anxiety Disorders)
Browse Figure
Versions Notes

Abstract

:
This study assessed prevalence of perinatal depression symptoms (PNDS) during the COVID-19 pandemic among Arab and Jewish women in Israel and identified COVID-19-related risk factors for PNDS, while comparing Arab and Jewish women. Sample included 730 perinatal women (604 Jewish and 126 Arab) aged 19–45 years, who filled out an online self-report questionnaire. The questionnaire assessed several areas: perinatal experiences and exposure to COVID-19, social support, and financial and emotional impact. PNDS was measured by the Edinburgh Postnatal Depression Scale (EPDS). Prevalence of PNDS (EPDS ≥ 10) in the entire study population was 40.0%. Prevalence among Arab women was significantly higher compared to Jewish women (58% vs. 36%, PV < 0.001). Higher PNDS were significantly associated with anxiety symptoms (GAD ≥ 10) (PV < 0.001), stress related to COVID-19 (PV < 0.001), adverse change in delivery of healthcare services (PV = 0.025), and unemployment (PV = 0.002). PNDS has elevated more than twofold during COVID-19 in Israel. Such high rates of PNDS may potentially negatively impact women, and fetal and child health development. This situation requires special attention from public health services and policy makers to provide support and mitigation strategies for pregnant and postpartum women in times of health crises.

1. Introduction

The COVID-19 pandemic has had many adverse impacts on the health and wellbeing of populations worldwide. Yet one of the most vulnerable groups deserving of close examination is that of perinatal women. The perinatal period is a time of heightened risk for women to develop emotional distress, e.g., depression. Not surprisingly, given that anxiety is a major risk factor for depression [1,2], several studies have shown that a high incidence of mental illness occurs during the perinatal period [3,4,5], putting perinatal women at even higher risk for onset or worsening of their mental health [6].
Indeed, global pre-pandemic rates of perinatal depression (PND) were reported to be 12–20% [1,2]. PND is associated with stressful life events or environments, existing or a history of mental health conditions, marital conflict, unplanned pregnancy, lack of social support, low socioeconomic status, and diagnosis of adverse pregnancy outcomes such as miscarriage, preterm delivery, low birth weight, and adverse maternal health conditions [7,8]. Untreated PND adversely impacts women’s health, infant outcomes, mother–infant bonding, and subsequent offspring physical and emotional health and cognitive development, and PND had, even before the pandemic, already emerged as a major public health concern [2,9,10,11].
However, the global COVID-19 pandemic has introduced unique challenges that subject pregnant and postpartum women to various physiological and psychosocial changes, making them even more prone to distress [12,13]. COVID-19 can attack lung cells, the immune system, and vascular, renal, and gastrointestinal cells, and may lead to severe respiratory distress syndrome [14]. Additionally, the extensive discussions in the media and social networks regarding pandemic-related health risk issues, including increased risks of miscarriage and fetal malformations [15], as well as potential mother–child transmission and increased risk of negative newborn outcomes [16,17], were found to contribute to elevated levels of anxiety and stress among perinatal women [18,19]. Other characteristics of the pandemic period, such as loneliness and isolation due to deprivation of social and family support, a reduction in maternity services, the limited availability of medical resources, restricted travel to hospital appointments, financial difficulties, domestic conflicts, and abuse, all of which have increased worldwide, were found to contribute to increasing the incidence of PND symptoms [12,20,21]. Rates of PND during COVID-19 were reported around 31–40% [12,22]. One study conducted in Canada during COVID-19, for example, showed increased PND and anxiety symptoms (37% and 57%, respectively) compared to similar pre-pandemic pregnancy cohorts [23].

Perinatal Mental Health in Israel

Israel, with a multi-cultural population of approximately 9.291 million people, is comprised of a majority Jewish population and a large (21.1%) Arab minority [24]. Studies have shown that this minority population experiences socioeconomic and health inequalities at both the individual and neighborhood levels [25]. For instance, compared to the majority population, Arab society tends to have lower levels of education, income, and employment [26,27] as well as poorer self-rated health [28]. These inequalities have been attributed to insufficient infrastructure in Arab localities and longstanding discriminatory policies which themselves contribute to high stress [29], low social cohesion, high depression, anxiety, and intimate partner violence [25]. Indeed, findings of pre-pandemic studies examining perinatal period mental health have shown higher rates (16.3% to 43%) of depression among Arab women as compared to that (4.5–22.6%) in Jewish women [30,31,32,33,34,35].
Given the context of the COVID-19-pandemic-related psychological distress experienced by perinatal women and the short- and long-term effects suffered by them and their children, it is essential to explore the risk factors related to the COVID-19 pandemic that contribute to these adverse effects. Moreover, as Arab women in Israel are more vulnerable than their Jewish counterparts to psychological distress during the perinatal period and may be at even greater risk as a result of the spread of COVID-19 [36], in order to address the unique needs of each population it is important to explore the risk factors of mental health that are unique to COVID-19 in perinatal Arab and Jewish women. To the best of our knowledge, the current study is the first to assess the prevalence of perinatal depression symptoms (PNDS) during the COVID-19 pandemic in a nationwide sample of Israeli Arab and Jewish women with the aim of identifying pandemic-related PNDS risk factors.

2. Methods

2.1. Study Design and Participants

The population comprising this cross-sectional study consisted of women who were pregnant or up to six months postpartum. Study inclusion criteria included being 18 years of age or older, pregnant or a biological mother of a child six months old or younger, and Hebrew or Arabic speaking, as well as consenting to participate. The study was carried out from August 2020 to February 2021. Data from 972 participants were considered valid and, in this study, only women that completed the EPDS were included. Ultimately, data on 730 perinatal women (604 Jewish and 126 Arab) were included in the analysis.

2.2. Sample Size

No restrictions were set on participant enrollment. However, a representative sample size was calculated according to the previous year’s number of Israeli newborns. Thus, based on an α-level of 0.05, we estimated a minimum sample size of 300 participants.

2.3. Data Collection

Data for the current study were collected through an online, structured, self-report questionnaire in Hebrew and in Arabic. Participants were recruited through social media (i.e., Facebook, Instagram, and WhatsApp) as well as through the personal networks of colleagues and acquaintances of research team members. Participants were asked to click on the project’s website link and were then directed to the online questionnaire. Once there, they were asked to confirm a set of eligibility criteria regarding their age and pregnant or postpartum status. Next, they were asked for their consent to participate in the study after reading an electronic consent form presenting an overview of the study aims, content of the questions asked, potential risks and benefits, and ethical aspects. Finally, those who met the predefined inclusion criteria filled out the questionnaire, while those who did not were directed to a message thanking them for their interest and informing them of the required eligibility criteria for study participation. The questionnaire took approximately 20 min to complete.

2.4. Variables and Measures

2.4.1. Outcome Measures

Perinatal depression symptoms (PNDS)
Perinatal depression symptoms (PNDS) were measured by the Edinburgh Postnatal Depression Scale (EPDS) [37], the most widely used self-report scale designed to identify women at risk for PNDS [38]. Indicating how women felt during the previous week, this 10-item scale assesses symptoms of sadness, anxiety, and thoughts about death. Scores range from 0 to 30, with the depression level being the sum score of all items and higher scores indicating greater symptom severity. As women who score ≥10 are considered at risk for PNDS [39,40], this cutoff score was chosen for use in the current study. Validated Hebrew and Arabic translated versions of the EPDS were also used. Furthermore, a reliability test revealed that Cronbach’s alpha was 0.87 for the entire study, 0.88 for Jewish women and 0.84 for Arab women.

2.4.2. Independent Variable Measures

Socio-Demographic characteristics
Demographic information included ethnicity (a dichotomous variable with two categories, Jewish and Arab, determined by mother’s self-identification), age, marital status (divorced, separated, widowed, or other), educational level (high school or below, above high school, or academic degree), employment status (Working full-time, part-time, or casually or Not working [unemployed, on maternity leave, retired, housewife, or other]), woman’s income (With income [working full time, working part-time, or paid maternity leave] or No income [unpaid maternity leave, unpaid temporary leave, looking for job, student, unemployed, stay-at-home caregiver]), number of children (one child, two children, and ≥3 children), pregnancy status (pregnant or postpartum), gestational age, and baby’s age.
Anxiety symptoms were evaluated using validated Hebrew and Arabic translated versions of the Generalized Anxiety Disorder Screener (GAD-7) [41], which is based on criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV and DSM-IV-TR [42]. The seven items on this questionnaire assess worry, tension, restlessness, and irritability. The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3 to the response categories of ‘not at all’, ‘several days’, ‘more than half the days’, and ‘nearly every day’, respectively, then adding together the scores for the seven questions. The GAD-7 total score ranges from 0 to 21, with anxiety level represented by the sum score of all items, and with higher scores reflecting proportionally greater anxiety. A score of ≥10 is considered a risk for anxiety symptoms [41,43] and was used as a cutoff score in the current study. A reliability test revealed that Cronbach’s alpha for this study was 0.85 for the entire study, 0.84 for Jewish women, and 0.83 for Arab women.
Social support was determined by the direct question, “Currently, how supported do you feel by your social network?” Answers given were based on a seven-point Likert scale ranging from “not supported” to “very supported.” The scale was dichotomized by the median score into high (≥median score) and low (<median score) social support.
Diagnosis of COVID-19: two categories were included, positive to COVID-19 test and negative to COVID-19 test at any time during the pandemic.
Stress related to COVID-19 was determined by a single question concerning overall level of stress related to the pandemic. Answers given were based on a seven-point Likert scale ranging from 1 (No stress) to 7 (Highly stressed). This is one of the most accurate of the Likert scales, respondent is given seven different options to best reflect their feeling. This scale was dichotomized by the median score into high (≥median score) and low (<median score).
Changes in healthcare service delivery: this was determined by a single question regarding any change in perinatal health service due to the COVID-19 outbreak. Answers given were based on a five-point Likert scale ranging from 1 (significantly improved) to 5 (significantly worsened). The options include two extremes, two intermediate, and one neutral opinion measuring agreement with and likelihood of changes in healthcare delivery. The scale was dichotomized into three categories (improved, no change, and adverse).

2.5. Statistical Analysis

Statistical analyses were performed using SPSS software version 22. Bivariate analysis was performed to examine associations between the independent variables and PNDS using the Chi-square test and t-test. Multivariate logistic regression analyses were performed to identify risk factors for PNDS. All independent variables associated (p < 0.05) with PNDS in the bivariate analyses were included in the multivariate analysis. The OR and 95% confidence interval (95% CI) were computed.

2.6. Ethical Considerations

Ethical approval was obtained from Bar Ilan University’s ethics committee before the study commenced (062001/2). Electronic informed consent was obtained from all participants, and confidentiality related to all information provided has been ensured. Since the survey was distributed online, a debriefing procedure was made available; at the end of the survey, a list of up-to-date services and resources for emotional help was provided.

3. Results

Table 1 presents the distribution of variables for the entire study population as well as the differences between the two ethnic groups. The total sample included 730 pregnant and postpartum women (82.7% Jewish and 17.3% Arab). Several significant differences were found to exist between the two ethnic groups. For example, compared to their Jewish counterparts, Arab women were a bit younger and had more children, a greater proportion of them were married, and they were more likely to report low social support. Jewish women had a higher level of education, and a greater proportion of them were employed and earning an income during the pandemic. Regarding medical factors, as can also be seen in Table 1, a higher proportion of Arab women had tested positive for COVID-19, while more Jewish women reported adverse changes in healthcare service delivery.
Figure 1 shows that the prevalence of PNDS in the total study population was 40.0%, with significant differences between Arab and Jewish women. While prevalence of PNDS among Jewish women was found to be 36.3%, among Arab women it was found to be 57.9%.
Bivariate analysis of PNDS risk factors, using EPDS ≥ 10 as a cutoff score for indicating presence of PNDS, showed a higher prevalence of PNDS among women who reported symptoms of anxiety (GAD ≥ 10), were unemployed, reported stress related to the COVID-19 pandemic, and reported adverse changes in healthcare service delivery (Table 2).
Table 3 presents the results of a multivariate logistic regression model comparing women with EPDS scores ≥ 10 to women who scored lower than 10. All variables significantly associated with PNDS in the bivariate analysis as well as the variables indicating significant differences between the two ethnic groups in Table 1 were included as independent variables in the multivariate analysis. Subsequent analysis revealed that the likelihood of Arab women experiencing PNDS was five times greater (OR = 5.0, 95%, confidence intervals (CI) = 2.7–9.2) than the odds of Jewish women experiencing PNDS. Furthermore, the likelihood of experiencing PNDS was found to be more than 21 times greater for women who reported anxiety symptoms (GAD ≥ 10) (OR = 21.8, 95%, CI = 11.2–58.7), four times greater for those who reported stress related to the COVID-19 pandemic (OR = 4.3, 95% CI = 3.0–6.4), and three times greater for those who were unemployed (OR = 2.7, 95% CI = 1.5–4.9), compared to those who did not report anxiety symptoms or stress and were employed, respectively. In addition, participants who reported adverse changes in healthcare service delivery were at greater risk for PNDS compared to participants who reported no change or positive change in the delivery of healthcare services.

4. Discussion

The COVID-19 pandemic has dramatically affected the wellbeing and mental health of billions of people worldwide [44,45]. Changes in daily routine and restrictions in movement, together with the resulting confinement-related stress, financial insecurity, and burden of health concerns, have taken a heavy negative toll [46,47]. One of the most vulnerable groups impacted by these adverse circumstances is perinatal women at risk of PNDS [12,22]. The current study assessed the prevalence of PNDS in the Israeli Arab and Jewish population and the impact of several of its risk factors related to the COVID-19 pandemic. These two ethnic groups were found to differ significantly in terms of age, marital status, level of education, rate of employment, number of children, pregnancy status, social support, diagnosis of COVID-19, change in the delivery of healthcare services, and prevalence and level of PNDS (36.3% in Jewish and 57.9% in Arab women).
It is interesting to note that the prevalence of PNDS found in Jewish women in Israel is similar to that found in women in other countries during the COVID-19 pandemic. For example, the prevalence in perinatal women was found to be 36.4% in the U.S [48], 39.2% in perinatal women in Qatar [49], 37% in pregnant women in Canada [23], and 34.0% in postpartum women in Turkey [50]. These findings indicate that PNDS incidence has more than doubled during the COVID-19 pandemic compared to its pre-pandemic rates [1,2].
Yet the current study found the PNDS rate in Israeli Arab women to be considerably higher than the 20.8% to 43% reported by studies conducted during pre-pandemic times [30,31,32,34,35]. This significant increase may well be associated with their societal circumstances. Arab women in Israel, comprising a minority population, have relatively low socioeconomic status [51] and less access to healthcare services and mental health services, and thus an especially low awareness of PND [52]. Likewise, a high prevalence of PNDS during the COVID-19 pandemic in other populations of minority women has been reported by previous studies. Qualitative research conducted in Northern California in minority pregnant and postpartum women found that those who reported PNDS faced individual, social, and healthcare service barriers to PND treatment [53]. Another study conducted in minority perinatal women with low-income status in the US showed that during the pandemic these women experienced increased stress and decreased social support [54].
Regarding the positive association between anxiety symptoms (GAD ≥ 10) and PNDS, the current study revealed that differences between Jewish and Arab women in scoring 10 or above on the GAD were not significant (13.7% and 12.2%, respectively). However, women who scored 10 or above on the GAD were more than 20 times more likely to report PNDS than those who scored GAD < 10. This positive association between PNDS and anxiety symptoms has been frequently reported [3,55,56,57]; in fact, having a history of anxiety disorders is one of the strongest predictors of PNDS [20,48].
Looking at other risk factors associated with pandemic-time PNDS addressed in the current study, three risk factors, i.e., unemployment, COVID-19-related stress, and negative changes in the delivery of healthcare services, in particular, were found to be dramatically reflective of these adverse times. It was found that 75% of Jewish women were employed compared to only 47.8% of Arab women. This rate of employment, while similar to the pre-pandemic rate for Arab women, is only a bit lower than the pre-pandemic rate (80%) for Jewish women [26]. The current study also showed that the likelihood of PNDS experienced by unemployed women was 2.7 times higher than that for employed women. Not surprisingly, unemployment is associated with food insecurity, domestic violence, and depression in pregnant and postpartum women [58,59]. Research has further suggested that poverty is a powerful predictor of depression and, as such, disproportionately affects low-income women [60].
Moreover, the current study found that stress related to COVID-19 affected both Jewish and Arab women, 38.7% and 32.2%, respectively. However, participants who were extremely concerned about stress related to COVID-19 constituted 61.8% of the group reporting PNDS. This group’s likelihood of PNDS was 4.6 times higher than that of study participants who reported relatively little concern about stress related to COVID-19 issues. Another study conducted in Israel during the pandemic revealed that Arab women were more anxious than Jewish women about several pandemic-related issues [36] such as being in public places, using public transportation, the need to attend pregnancy follow-up at hospitals or women’s health clinics, and delivery during the pandemic [36]. Some of the concerns raised by this study include how people of low socioeconomic status are characterized as being dependent on public transportation, avoiding public places, and having a lack of access to public health services. These findings correspond to the current study’s results, which indicate a higher PNDS prevalence among Arab women, an ethno-national minority in Israel characterized as having a low socioeconomic status [27].
Finally, the present study showed that a change in delivery of healthcare services in Israel during the pandemic was significantly associated with PNDS, i.e., participants reporting an adverse change were at significantly higher risk for PNDS (OR = 3.6). Substantial changes in the delivery of healthcare services have been made in several other countries as well, in an effort to minimize transmission risks [61]. Such changes include minimizing face-to-face care, physical-distancing restrictions, reducing care, limiting women’s escorts during appointments and childbirth, and restricting visitors to maternity wards [62,63]. Additional studies have reported that perinatal women experience high levels of concern about birth expectations, as well as report feelings of fear and loneliness [64], while postpartum women are concerned about breastfeeding and infant weight gain due to lack of face-to-face contact with health professionals [65].
The current study found no association between PNDS and education, women’s income status, social support, or diagnosis of COVID-19. By comparison, previous studies have shown that low education, lack of social support, and lower income are indeed risk factors for PNDS [30,66]. A partial explanation for this discrepancy may lay in the extreme stress that perinatal women have endured due to the pandemic. For example, during two periods of lockdown in Israel between March 2020 and February 2021, fear and anxiety were common, particularly to people at high risk for COVID-19 infection, such as pregnant women [67,68]. While in ordinary non-pandemic times education and social support may function as protective factors by enhancing feelings of self-efficacy [13,69], in times of pandemic outbreak, worldwide anxiety level, particularly that of perinatal women, may be elevated to such an unprecedented level that education may no longer serve as a protective factor. Furthermore, as a result of lockdowns and social distancing, the pre-pandemic face-to-face support women were accustomed to receiving may not be available [70]. Therefore, they may be disappointed with the change in the way social support has in recent pandemic times been delivered. Further studies are necessary to examine and further understand these issues; regardless, these findings suggest there exists a considerable challenge to healthcare services to implement screening techniques that identify and implement programs to support women who suffer from PND.

Limitations

The current study has some limitations. First, because of its cross-sectional design, no causal effects can be implied between its independent variables and PNDS. In addition, data were collected through an online survey and based on participants’ self-reports, a procedure which might result in self-report bias. Another limitation is the lack of screening for psychiatric conditions. Since participants are not physically in a face-to-face setting, it was impossible to conduct a clinical diagnosis of depression by a physician. However, at the end of the questionnaire, we provided information about seeking professional consultation for PND. In addition, the questionnaire for assessing anxiety disorders (GAD) refers only to general anxiety and in future studies, it might be advisable to include instruments that assess other types of anxiety disorders such as panic disorder and social phobia. Furthermore, the group of study participants did not include women under the age of 18. Thus, the current study may not represent a comprehensive range of mental health needs of perinatal women, especially those who may be disproportionately affected, e.g., with limited internet access or pregnant teens, by the pandemic. Nonetheless, it provides important insights into the state of PND and its associated risk factors in Israeli Arab and Jewish women during the COVID-19 pandemic.

5. Conclusions

To the best of our knowledge, this is the first study conducted on a nationwide sample of Israeli Jewish and Arab women assessing the prevalence of PNDS and COVID-19-related PNDS risk factors. The study highlights the phenomenon of elevated PND symptoms in pregnant and postpartum women, one of the most vulnerable groups in the population, during the pandemic. Study findings also point to a high prevalence of PNDS in Arab and Jewish women, 57.9% and 36.3%, respectively. Such high rates of PNDS have potentially negative implications not only for women, but also for fetal health and development; this alarming situation requires special attention from public health services. Most of the risk factors, including elevated rates of anxiety (GAD > 10), pandemic-related stress, unemployment, and negative changes in healthcare service delivery, elucidated by the current study can be directly attributed to the pandemic. However, it must be noted that one prominent risk factor for PNDS is ethnic identity. Arab women in general have relatively poor healthcare service access and a low awareness of PND, and reside in low-income households badly affected by the pandemic. Given the well-established evidence of how PND affects the wellbeing of women and their families, as well as the development of their offspring, it has proven crucial, especially during the pandemic, to screen, prevent, monitor, and target for treatment a range of mental health symptoms and emotional wellbeing. It would be advisable to make available to women during their perinatal period a variety of intervention programs, e.g., online therapy, adapted to pandemic periods. We also suggest preventive interventions before or early during pregnancy that improve sense of social support, involved parenting skills, perinatal education with follow-up, and increase knowledge about PND and improve access to healthcare, might contribute to PND prevention especially in women at risk and the disadvantaged population. This includes preventive interventions that taking place in primary care, perinatal obstetrics/gynecology, pediatric clinics, or other community settings. Additionally, health policy makers and health organizations might notify pediatric providers that children of depressed mothers are at risk of developmental and behavioral problems and suggest conducting a regular developmental evaluation of the child, offer guidance, and refer them early for more comprehensive assessment and management of developmental and behavioral disorders.

Author Contributions

Conceptualization, S.A.-Z., R.B., and D.L.; methodology, S.A.-Z., R.B. and D.L.; validation, S.A.-Z., R.B. and D.L.; formal analysis, S.A.-Z. and R.M.; investigation, S.A.-Z., R.B. and D.L.; resources, S.A.-Z., R.B., D.L. and A.Z.; data curation, S.A.-Z., R.B., D.L. and A.Z.; writing—original draft preparation, S.A.-Z.; writing—review and editing, S.A.-Z., R.B., D.L., R.M. and A.Z.; visualization, S.A.-Z., R.B., D.L., R.M. and A.Z.; funding acquisition, R.B., D.L., R.M. and A.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Bar-Ilan Dangoor Centre for Personalized Medicine, grant number “REFU/DANGO/100”.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Committee of Bar Ilan University (protocol code: 062001/2, date of approval: 06.2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

This article is based on work from COST Action CA18138 “Research Innovation and Sustainable Pan-European Network in Peripartum Depression Disorder” (Riseup-PPD) and was supported by COST (European Cooperation in Science and Technology; https://www.cost.eu/, accessed 18 October 2021). We acknowledge the support from Bar-Ilan Dangoor Centre for Personalized Medicine, Israel. We are grateful to Smadar Freiberg for her contribution to the questionnaire distribution and to the study participants for their cooperation and patience.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. O’Hara, M.W.; Wisner, K.L. Perinatal mental illness: Definition, description and etiology. Best Pr. Res. Clin. Obstet. Gynaecol. 2014, 28, 3–12. [Google Scholar] [CrossRef] [PubMed]
  2. Woody, C.A.; Ferrari, A.J.; Siskind, D.J.; Whiteford, H.A.; Harris, M.G. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J. Affect Disord. 2017, 219, 86–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bina, R.; Harrington, D. Differential Predictors of Postpartum Depression and Anxiety: The Edinburgh Postnatal Depression Scale Hebrew Version Two Factor Structure Construct Validity. Matern. Child Health J. 2017, 21, 2237–2244. [Google Scholar] [CrossRef] [PubMed]
  4. Alipour, Z.; Lamyian, M.; Hajizadeh, E. Anxiety and fear of childbirth as predictors of postnatal depression in nulliparous women. Women Birth J. Aust. Coll. Midwives 2012, 25, e37–e43. [Google Scholar] [CrossRef]
  5. Gavin, N.I.; Gaynes, B.N.; Lohr, K.N.; Meltzer-Brody, S.; Gartlehner, G.; Swinson, T. Perinatal depression: A systematic review of prevalence and incidence. Obstet Gynecol. 2005, 106, 1071–1083. [Google Scholar] [CrossRef]
  6. Smith, E.K.; Gopalan, P.; Glance, J.B.; Azzam, P.N. Postpartum Depression Screening: A Review for Psychiatrists. Harv. Rev. Psychiatry 2016, 24, 173–187. [Google Scholar] [CrossRef]
  7. Nicolet, L.; Moayedoddin, A.; Miafo, J.D.; Nzebou, D.; Stoll, B.; Jeannot, E. Teenage Mothers in Yaoundé, Cameroon—Risk Factors and Prevalence of Perinatal Depression Symptoms. J. Clin. Med. 2021, 10, 4164. [Google Scholar] [CrossRef]
  8. Fairbrother, N.; Young, A.H.; Janssen, P.; Antony, M.M.; Tucker, E. Depression and anxiety during the perinatal period. BMC Psychiatry 2015, 15, 206. [Google Scholar] [CrossRef] [Green Version]
  9. Gentile, S. Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review. Neuroscience 2017, 342, 154–166. [Google Scholar] [CrossRef]
  10. Dennis, C.; Falah-Hassani, K.; Shiri, R. Prevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis. Br. J. Psychiatry 2017, 210, 315–323. [Google Scholar] [CrossRef]
  11. Netsi, E.; Pearson, R.M.; Murray, L.; Cooper, P.; Craske, M.G.; Stein, A. Association of Persistent and Severe Postnatal Depression With Child Outcomes. JAMA Psychiatry 2018, 75, 247–253. [Google Scholar] [CrossRef] [Green Version]
  12. Basu, A.; Kim, H.H.; Basaldua, R.; Choi, K.W.; Charron, L.; Kelsall, N.; Hernandez-Diaz, S.; Wyszynski, D.F.; Koenen, K.C. A cross-national study of factors associated with women's perinatal mental health and wellbeing during the COVID-19 pandemic. PLoS ONE 2021, 16, e0249780. [Google Scholar] [CrossRef]
  13. Biaggi, A.; Conroy, S.; Pawlby, S.; Pariante, C.M. Identifying the women at risk of antenatal anxiety and depression: A systematic review. J. Affect Disord. 2015, 191, 62–77. [Google Scholar] [CrossRef] [Green Version]
  14. Astuti, I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & metabolic syndrome clinical research & reviews. Diabetes Metab. Syndr. 2020, 14, 407–412. [Google Scholar]
  15. Topalidou, A.; Thomson, G.; Downe, S. COVID-19 and maternal mental health: Are we getting the balance right? medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  16. Juan, J.; Gil, M.M.; Rong, Z.; Zhang, Y.; Yang, H.; Poon, L.C. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: Systematic review. Ultrasound Obstet. Gynecol. 2020, 56, 15–27. [Google Scholar] [CrossRef]
  17. Dashraath, P.; Wong, J.L.J.; Lim, M.X.K.; Lim, L.M.; Li, S.; Biswas, A.; Choolani, M.; Mattar, C.; Su, L.L. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Obstet. Gynecol. 2020, 222, 521–531. [Google Scholar] [CrossRef]
  18. Chivers, B.R.; Garad, R.M.; Boyle, J.A.; Skouteris, H.; Teede, H.J.; Harrison, C.L. Perinatal Distress During COVID-19: Thematic Analysis of an Online Parenting Forum. J. Med. Internet Res. 2020, 22, e22002. [Google Scholar] [CrossRef]
  19. NanjundaSwamy, M.H.; Shiva, L.; Desai, G.; Ganjekar, S.; Kishore, T.; Ram, U.; Satyanarayana, V.; Thippeswamy, H.; Chandra, P.S. COVID-19-related anxiety and concerns expressed by pregnant and postpartum women—A survey among obstetricians. Arch. Womens Ment. Health 2020, 23, 787–790. [Google Scholar] [CrossRef]
  20. Baran, J.; Leszczak, J.; Baran, R.; Biesiadecka, A.; Weres, A.; Czenczek-Lewandowska, E.; Kalandyk-Osinko, K. Prenatal and Postnatal Anxiety and Depression in Mothers during the COVID-19 Pandemic. J. Clin. Med. 2021, 10, 3193. [Google Scholar] [CrossRef]
  21. Kotlar, B.; Gerson, E.; Petrillo, S.; Langer, A.; Tiemeier, H. The impact of the COVID-19 pandemic on maternal and perinatal health: A scoping review. Reproductive health. Reprod. Health 2021, 18, 10. [Google Scholar] [CrossRef]
  22. Shorey, S.Y.; Ng, E.D.; Chee, C.Y.I. Anxiety and depressive symptoms of women in the perinatal period during the COVID-19 pandemic: A systematic review and meta-analysis. Scand. J. Public Health 2021, 49, 730–740. [Google Scholar] [CrossRef]
  23. Lebel, C.; MacKinnon, A.; Bagshawe, M.; Tomfohr-Madsen, L.; Giesbrecht, G. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. J. Affect. Disord. 2020, 277, 5–13. [Google Scholar] [CrossRef]
  24. Central Bureau of Statistics. Population of Israel. 2021. Available online: https://www.cbs.gov.il/en/mediarelease/Pages/2020/Population-of-Israel-on-the-Eve-of-2021.aspx (accessed on 1 October 2021).
  25. Daoud, N.; Sergienko, R.; O’Campo, P.; Shoham-Vardi, I. Disorganization Theory, Neighborhood Social Capital, and Ethnic Inequalities in Intimate Partner Violence between Arab and Jewish Women Citizens of Israel. J. Urban Health 2017, 94, 648–665. [Google Scholar] [CrossRef]
  26. Central Bureau of Statistics. Labour Force Survey, Israel. 2019. Available online: https://www.cbs.gov.il/en/publications/Pages/2021/Labour-Force-Survey-2019.aspx (accessed on 1 October 2021).
  27. Kasir, N.; Yashiv, E. The Economic Outcomes of an Ethnic Minority: The Role of Barriers. The IZA Institute of Labor Economics. 2020. Available online: https://www.iza.org/publications/dp/13120/the-economic-outcomes-of-an-ethnic-minority-the-role-of-barriers (accessed on 1 October 2021).
  28. Daoud, N.; Soskolne, V.; Mindell, J.S.; Roth, M.A.; Manor, O. Ethnic inequalities in health between Arabs and Jews in Israel: The relative contribution of individual-level factors and the living environment. Int. J. Public Health 2017, 63, 313–323. [Google Scholar] [CrossRef]
  29. Osman, A.; Daoud, N.; Thrasher, J.F.; Bell, B.A.; Walsemann, K.M. Ethnic Discrimination and Smoking-Related Outcomes among Former and Current Arab Male Smokers in Israel: The Buffering Effects of Social Support. J. Immigr. Minority Health 2017, 20, 1094–1102. [Google Scholar] [CrossRef]
  30. Alfayumi-Zeadna, S.; Froimovici, M.; Rourke, N.O.; Azbarga, Z.; Okby-Cronin, R.; Salman, L.; Alkatnany, A.; Grotto, I.; Daoud, N. Direct and indirect determinants of prenatal depression among Arab-Bedouin women in Israel: The role of stressful life events and social support. Midwifery 2021, 96, 102937. [Google Scholar] [CrossRef]
  31. Shwartz, N.; Shoahm-Vardi, I.; Daoud, N. Postpartum depression among Arab and Jewish women in Israel: Ethnic inequalities and risk factors. Midwifery 2019, 70, 54–63. [Google Scholar] [CrossRef] [PubMed]
  32. Alfayumi-Zeadna, S.; Kaufman-Shriqui, V.; Zeadna, A.; Lauden, A.; Shoham-Vardi, I. The association between sociodemographic characteristics and postpartum depression symptoms among Arab-Bedouin women in Southern Israel. Depress. Anxiety 2015, 32, 120–128. [Google Scholar] [CrossRef] [PubMed]
  33. Polachek, I.S.; Harari, L.H.; Baum, M.; Strous, R.D. Postpartum anxiety in a cohort of women from the general population: Risk factors and association with depression during last week of pregnancy, postpartum depression and postpartum PTSD. Isr. J. Psychiatry. 2014, 51, 128–134. [Google Scholar]
  34. Glasser, S.; Tanous, M.; Shihab, S.; Goldman, N.; Ziv, A.; Kaplan, G. Perinatal depressive symptoms among Arab women in Northern Israel. Matern Child Health J. 2012, 16, 1197–1205. [Google Scholar] [CrossRef]
  35. Glasser, S.; Stoski, E.; Kneler, V.; Magnezi, R. Postpartum depression among Israeli Bedouin women. Arch. Womens Ment. Health 2011, 14, 203–208. [Google Scholar] [CrossRef]
  36. Taubman-Ben-Ari, O.; Chasson, M.; Abu Sharkia, S.; Weiss, E. Distress and anxiety associated with COVID-19 among Jewish and Arab pregnant women in Israel. J. Reprod. Infant Psychol. 2020, 38, 340–348. [Google Scholar] [CrossRef]
  37. Cox, J.L.; Holden, J.M.; Sagovsky, R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 1987, 150, 782–786. [Google Scholar] [CrossRef] [Green Version]
  38. Cox, J. Thirty years with the Edinburgh Postnatal Depression Scale: Voices from the past and recommendations for the future. Br. J. Psychiatry 2019, 214, 127–129. [Google Scholar] [CrossRef] [Green Version]
  39. Levis, B.; Negeri, Z.; Sun, Y.; Benedetti, A.; Thombs, B. Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for screening to detect major depression among pregnant and postpartum women: Systematic review and meta-analysis of individual participant data. BMJ 2020, 371, m4022. [Google Scholar] [CrossRef]
  40. Gibson, J.; McKenzie-McHarg, K.; Shakespeare, J.; Price, J.; Gray, R. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr. Scand. 2009, 119, 350–364. [Google Scholar] [CrossRef]
  41. Spitzer, R.L.; Kroenke, K.; Williams, J.B.W.; Löwe, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006, 166, 1092–1097. [Google Scholar] [CrossRef] [Green Version]
  42. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association: Washington, DC, USA, 2013. [Google Scholar]
  43. Fawcett, E.J.; Fairbrother, N.; Cox, M.L.; White, I.R.; Fawcett, J.M. The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period: A Multivariate Bayesian Meta-Analysis. J. Clin. Psychiatry 2019, 80, 18r12527. [Google Scholar] [CrossRef]
  44. Lades, L.K.; Laffan, K.; Daly, M.; Delaney, L. Daily emotional well-being during the COVID-19 pandemic. Br. J. Health Psychol. 2020, 25, 902–911. [Google Scholar] [CrossRef]
  45. O’Connor, R.C.; Wetherall, K.; Cleare, S.; McClelland, H.; Melson, A.J.; Niedzwiedz, C.L.; O’Carroll, R.E.; O’Connor, D.B.; Platt, S.; Scowcroft, E.; et al. Mental health and well-being during the COVID-19 pandemic: Longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br. J. Psychiatry 2020, 218, 1–333. [Google Scholar]
  46. Prime, H.; Wade, M.; Browne, D.T. Risk and Resilience in Family Well-Being During the COVID-19 Pandemic. Am. Psychol. 2020, 75, 631–643. [Google Scholar] [CrossRef] [PubMed]
  47. Otu, A.; Charles, C.H.; Yaya, S. Mental health and psychosocial well-being during the COVID-19 pandemic: The invisible elephant in the room. Int. J. Ment. Health Syst. 2020, 14, 1–38. [Google Scholar] [CrossRef] [PubMed]
  48. Liu, C.H.; Erdei, C.; Mittal, L. Risk factors for depression, anxiety, and PTSD symptoms in perinatal women during the COVID-19 Pandemic. Psychiatry Res. 2021, 295, 113552. [Google Scholar] [CrossRef]
  49. Farrell, T.; Reagu, S.; Mohan, S.; Elmidany, R.; Qaddoura, F.; Ahmed, E.E.; Corbett, G.; Lindow, S.; Abuyaqoub, S.M.; Alabdulla, M.A. The impact of the COVID-19 pandemic on the perinatal mental health of women. J. Perinat. Med. 2020, 48, 971–976. [Google Scholar] [CrossRef]
  50. Guvenc, G.; Yesilcinar, I.; Ozkececi, F.; Öksüz, E.; Ozkececi, C.F.; Konukbay, D.; Kok, G.; Karasahin, K.E. Anxiety, depression, and knowledge level in postpartum women during the COVID-19 pandemic. Perspect. Psychiatr. Care 2021, 57, 1449–1458. [Google Scholar] [CrossRef]
  51. Benyamini, Y.; Boyko, V.; Blumstein, T.; Lerner-Geva, L. Health, Cultural and Socioeconomic Factors Related to Self-Rated Health of Long-Term Jewish Residents, Immigrants, and Arab Women in Midlife in Israel. Women Health 2014, 54, 402–424. [Google Scholar] [CrossRef]
  52. Alfayumi-Zeadna, S.; Froimovici, M.; Azbarga, Z.; Grotto, I.; Daoud, N. Barriers to postpartum depression treatment among Indigenous Bedouin women in Israel: A focus group study. Health & social care in the community. Health Soc. Care Community 2019, 27, 757–766. [Google Scholar]
  53. Iturralde, E.; Hsiao, C.A.; Nkemere, L.; Kubo, A.; Sterling, S.A.; Flanagan, T.; Avalos, L.A. Engagement in perinatal depression treatment: A qualitative study of barriers across and within racial/ethnic groups. BMC Pregnancy Childbirth 2021, 21, 512. [Google Scholar] [CrossRef]
  54. Barbosa-Leiker, C.; Smith, C.L.; Crespi, E.J.; Brooks, O.; Burduli, E.; Ranjo, S.; Carty, C.L.; Hebert, L.E.; Waters, S.F.; Gartstein, M.A. Stressors, coping, and resources needed during the COVID-19 pandemic in a sample of perinatal women. BMC Pregnancy Childbirth 2021, 21, 171. [Google Scholar] [CrossRef]
  55. Britton, J.R. Maternal anxiety: Course and antecedents during the early postpartum period. Depress. Anxiety 2008, 4, 793–800. [Google Scholar] [CrossRef]
  56. Miller, R.L.; Pallant, J.F.; Negri, L.M. Anxiety and stress in the postpartum: Is there more to postnatal distress than depression? BMC Psychiatry 2006, 6, 12. [Google Scholar] [CrossRef] [Green Version]
  57. Farr, S.L.; Dietz, P.M.; O’Hara, M.W.; Burley, K.; Ko, J.Y. Postpartum Anxiety and Comorbid Depression in a Population-Based Sample of Women. J. Womens Health 2014, 23, 12–128. [Google Scholar] [CrossRef]
  58. Abrahams, Z.; Boisits, S.; Schneider, M.; Prince, M.; Lund, C. The relationship between common mental disorders (CMDs), food insecurity and domestic violence in pregnant women during the COVID-19 lockdown in Cape Town, South Africa. Soc. Psychiatry Psychiatr. Epidemiol. 2021. [Google Scholar] [CrossRef]
  59. Wang, D.; Li, Y.; Qiu, D.; Xiao, S. Factors Influencing Paternal Postpartum Depression: A Systematic Review and Meta-Analysis. J. Affect Disord 2021, 293, 51–63. [Google Scholar] [CrossRef]
  60. Liu, C.H.; Tronick, E. Rates and Predictors of Postpartum Depression by Race and Ethnicity: Results from the 2004 to 2007 New York City PRAMS Survey (Pregnancy Risk Assessment Monitoring System). Matern Child Health J. 2012, 17, 1599–1610. [Google Scholar] [CrossRef]
  61. Rochelson, B.; Nimaroff, M.; Combs, A.; Schwartz, B.; Meirowitz, N.; Vohra, N.; Klein, V.R.; Santandreu, O.; Kramer, M.; Mootabar, N.; et al. The care of pregnant women during the COVID-19 pandemic—response of a large health system in metropolitan New York. J. Perinat. Med. 2020, 48, 453–461. [Google Scholar] [CrossRef]
  62. Mayopoulos, G.A.; Ein-Dor, T.; Li, K.G.; Chan, S.J.; Dekel, S. COVID-19 positivity associated with traumatic stress response to childbirth and no visitors and infant separation in the hospital. Sci. Rep. 2021, 11, 13535. [Google Scholar] [CrossRef]
  63. Farmer, N.; Connor, M. Reducing the risk of infection to patients and staff during gynaecological outpatient and ambulatory appointments. Best Pract. Res. Clin. Obstet. Gynaecol. 2021, 73, 22–39. [Google Scholar] [CrossRef]
  64. Ravaldi, C.; Wilson, A.; Ricca, V.; Homer, C.; Vannacci, A. Pregnant women voice their concerns and birth expectations during the COVID-19 pandemic in Italy. Women Birth J. Aust. Coll. Midwives 2021, 34, 335–343. [Google Scholar] [CrossRef]
  65. Hull, N.; Kam, R.L.; Gribble, K.D. Providing breastfeeding support during the COVID-19 pandemic: Concerns of mothers who contacted the Australian Breastfeeding Association. Breastfeed. Rev. 2020, 28, 25–35. [Google Scholar]
  66. Dagher, R.K.; Bruckheim, H.E.; Colpe, L.J.; Edwards, E.; White, D.B. Perinatal Depression: Challenges and Opportunities. J. Womens Health 2021, 30, 154–159. [Google Scholar] [CrossRef]
  67. Cheng, S.O.; Khan, S.; Alsafi, Z. Maternal death in pregnancy due to COVID-19. Ultrasound Obs. Gynecol. 2020, 56, 122. [Google Scholar] [CrossRef]
  68. Ghelichkhani, S.; Jenabi, E.; Jalili, E.; Alishirzad, A.; Shahbazi, F. Pregnancy outcomes among SARS-CoV-2-infected pregnant women with and without underlying diseases: A case-control study. J. Med. Life 2021, 14, 518–522. [Google Scholar] [CrossRef]
  69. Milgrom, J.; Hirshler, Y.; Reece, J.; Holt, C.; Gemmill, A.W. Social Support-A Protective Factor for Depressed Perinatal Women? Int. J. Environ. Res. Public Health 2019, 16, 1426. [Google Scholar] [CrossRef] [Green Version]
  70. Motrico, E.; Bina, R.; Domínguez-Salas, S.; Mateus, V.; Contreras-García, Y.; Carrasco-Portiño, M.; Ajaz, E.; Apter, G.; Christoforou, A.; Dikmen-Yildiz, P.; et al. Impact of the Covid-19 pandemic on perinatal mental health (Riseup-PPD-COVID-19): Protocol for an international prospective cohort study. BMC Public Health 2021, 21, 368. [Google Scholar] [CrossRef]
Jcm 11 00349 g001 550
Figure 1. Prevalence of perinatal depression symptoms in total study sample and in Jewish and Arab women. p = significance level for the association between Arab and Jewish women (Chi-square test).
Figure 1. Prevalence of perinatal depression symptoms in total study sample and in Jewish and Arab women. p = significance level for the association between Arab and Jewish women (Chi-square test).
Jcm 11 00349 g001
Table
Table 1. Sociodemographic characteristics of Arab and Jewish women (Total N = 730).
Table 1. Sociodemographic characteristics of Arab and Jewish women (Total N = 730).
Total
730 (100%)		Jewish Women
604 (82.7%)		Arab Women
126 (17.3%)
VariablesN (%)N (%)N (%)PV
Age (Mean (SD) Range)31.5 (4.9), 19–4531.9 (5.0), 19–4529.9 (3.9), 21–41<0.000
Education <0.000
Academic degree595 (81.5)524 (89.1)71 (57.7)
Non-Academic degree116 (15.9)64 (10.9)52 (42.3)
Marital status 0.005
Married674 (94.8)554 (93.7)120 (100%)
Unmarried37 (5.2)37 (6.3)0
Employment status 0.009
Employed613 (85.7)525 (85.6)25 (22.1)
Unemployed102 (14.3)77 (12.8)88 (78.0)
Woman’s income <0.000
With income 490 (71.4)427 (75.0)43 (47.8)
No income196 (28.6)149 (25.0)47 (52.2)
Number of children <0.000
038 (5.7)18 (3.3)20 (17.2)
1–2418 (62.5)366 (66.2)52 (44.8)
≥3213 (31.8)169 (30.6)44 (37.9)
Pregnancy status 0.001
Pregnant309 (42.3)239 (39.6)70 (55.6)
Postpartum421 (57.7)365 (60.4)56 (44.4)
Gestational age (Mean (SD) Range)26.0 (9.1), 4–4125.7 (9.2), 14–4127.0 (7.9), 12–380.297
Baby’s age (weeks) (Mean (SD)Range)13.2(7.2), 0–3013.6 (7.1), 0–3011.3 (6.1), 4–240.017
Anxiety symptoms 0.659
GAD < 10606 (86.6)498 (82.2)108 (87.8)
GAD ≥ 1094 (13.4)79 (13.7)15 (12.2)
Social support 0.011
Low358 (49.7)312 (51.7)46 (39.0)
High363 (50.3)291 (48.3)72 (61.0)
Diagnosis of COVID-19 <0.000
Positive682 (94.1)581 (96.4)101 (83.5)
Negative42 (5.8)22 (3.6)20 (16.5)
Stress related to COVID-19 0.157
Low450 (62.1)368 (60.9)82 (67.8)
High236 (39.1)251 (38.7)39 (32.2)
Changes in healthcare service delivery <0.000
Positive change27 (3.8)12 (2.1)15 (12.4)
No change398 (56.6)321 (55.2)77 (63.6)
Adverse change278 (39.5)249 (42.8)29 (24.0)
Table
Table 2. Individual characteristics and risk factors related to COVID-19 and associations with PNDS (N = 730).
Table 2. Individual characteristics and risk factors related to COVID-19 and associations with PNDS (N = 730).
EPDS < 10
N = 438 (60.0%)		EPDS ≥ 10
N = 292 (40.0%)
VariablesN (%)N (%)PV
Ethnicity <0.001
Jewish385 (63.7)219 (36.3)
Arab53 (42.1)73 (57.9)
Age (Mean (SD) Range)31.60 (4.82), 21–4831.49 (4.98), 19–460.788
Education 0.408
Academic degree363 (61.0)232 (39.0)
Non-Academic degree66 (56.9)50 (43.1)
Marital status 0.575
Married406 (60.2)268 (39.8)
Unmarried24 (64.9)13 (35.1)
Employment status 0.001
Employed386 (63)227 (37)
Unemployed46 (45.1)56 (54.9)
Woman’s income 0.194
With income267 (62.5)160 (37.5)
No income149 (57.5)110 (42.5)
Number of children 0.512
023 (60.5)15 (39.5)
1–2245 (58.6)173 (41.4)
≥3135 (63.4)78 (36.6)
Pregnancy status 0.603
Pregnant182 (58.9)127 (41.1)
Postpartum256 (60.8)165 (39.2)
Gestational age (Mean (SD) Range)26.48 (9.17), 6–4025.17 (8.74), 6–400.222
Age of baby (weeks) (Mean (SD) Range)13.10 (6.95), 0–2913.75 (7.19), 1–290.353
Anxiety symptoms
GAD < 10413 (68.2)193 (31.8)<0.000
GAD ≥ 106 (6.4)88 (93.6)
Social support 0.649
Low213 (59.5)145 (40.5)
High222 (61.2)141 (38.8)
Diagnosis of COVID-19 0.661
Negative413 (60.6)269 (39.4)
Positive24 (57.1)18 (42.9)
Stress related to COVID-19 0.000
Low333 (74)117 (26)
High105 (38.2)170 (61.8)
Changes in healthcare service delivery 0.003
Positive change14 (51.9)13 (48.1)
No change262 (65.8)136 (34.2)
Adverse change148 (53.2)130 (46.8)
Table
Table 3. Factors associated with PNDS (EPDS ≥ 10) as per multivariate logistic regression analysis.
Table 3. Factors associated with PNDS (EPDS ≥ 10) as per multivariate logistic regression analysis.
VariableOR (95%CI)PV
Ethnicity <0.001
Jewish1 (ref)
Arab5.0 (2.7–9.2)
Anxiety symptoms <0.001
GAD < 101
GAD ≥ 1021.8 (11.2–58.7)
Employment status 0.002
Employed1
Unemployed2.7 (1.5–4.9)
Woman’s income 0.166
With income1
No income1.4 (0.8–2.4)
Education 0.092
Academic degree1
Non-Academic degree1.7 (0.9–3.3)
Stress related to COVID-19 pandemic <0.001
Low1
High4.3 (3.0–6.4)
Changes in healthcare service delivery
Positive change1
No change2.2 (0.6–8.6)0.050
Adverse change3.7 (1.1–14.1)0.025
Social support 0.401
High1
Low1.2 (0.8–1.8)
Diagnosis of COVID-19 0.562
Negative1
Positive1.3 (0.5–3.2)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alfayumi-Zeadna, S.; Bina, R.; Levy, D.; Merzbach, R.; Zeadna, A. Elevated Perinatal Depression during the COVID-19 Pandemic: A National Study among Jewish and Arab Women in Israel. J. Clin. Med. 2022, 11, 349. https://doi.org/10.3390/jcm11020349

AMA Style

Alfayumi-Zeadna S, Bina R, Levy D, Merzbach R, Zeadna A. Elevated Perinatal Depression during the COVID-19 Pandemic: A National Study among Jewish and Arab Women in Israel. Journal of Clinical Medicine. 2022; 11(2):349. https://doi.org/10.3390/jcm11020349

Chicago/Turabian Style

Alfayumi-Zeadna, Samira, Rena Bina, Drorit Levy, Rachel Merzbach, and Atif Zeadna. 2022. "Elevated Perinatal Depression during the COVID-19 Pandemic: A National Study among Jewish and Arab Women in Israel" Journal of Clinical Medicine 11, no. 2: 349. https://doi.org/10.3390/jcm11020349

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop